Avantor entered into a multi-year supply and services agreement with Catalent under which Avantor will be the primary supplier of a range of laboratory supplies, clinical and production materials, and services to Catalent, expanding the companies’ existing relationship.
“We have seen firsthand that Avantor is a terrific partner that brings diverse capabilities and expertise across modalities and geographies, which is essential to meeting global health needs,” said Alessandro Maselli, president and CEO, Catalent.
“Catalent has built tremendous global capabilities and a reputation as a trusted collaborator to pharma, biotech and consumer health partners throughout the development and production lifecycle,” added Michael Stubblefield, president and CEO of Avantor. “We are pleased to expand our support for Catalent.”
